Answers are grounded in this paper and cite their sources.
The in vivo efficacy of vancomycin and teicoplanin against five Staphylococcus aureus strains with different susceptibilities to them and methicillin was studied. Rabbits were allocated at random to groups for endocarditis induction with one of these five strains and then treated for 2 days with vancomycin or teicoplanin. Each treated group was compared with a control group infected with the same strain. Vancomycin and teicoplanin showed similar activities. Low MICs did not predict better in vivo results.
No takes yet. Share an insight, caveat, or question.
Asseray et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: